COMPUGEN LTD

Profile

Company Names

COMPUGEN LTD

Addresses

26 HAROKMIM STREET, BUILDING D, HOLON, L3 5885849

Phone Numbers

011-972-3-765-8585

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER

Year Incorporated:

> 5 years ago

State Incorporated:

ISRAEL

Total Amount Raised:

$32,000,000.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2021-11-10 
$20,000,000.00 
$20,000,000.00 
$0.00 
Equity 
1
2018-10-11 
$12,000,000.00 
$12,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
HENRY 
 
ADEWOYE 
EXECUTIVE OFFICER
COMPUGEN LTD
YAIR 
 
AHARONOWITZ 
DIRECTOR
COMPUGEN LTD
JEAN-PIERRE 
 
BIZZARI 
DIRECTOR
PIERIS PHARMACEUTICALS, INC.   |  COMPUGEN LTD   |  APREA THERAPEUTICS, INC.
KIRK 
A. 
CHRISTOFFERSEN 
EXECUTIVE OFFICER
COMPUGEN LTD
ANAT 
 
COHEN-DAYAG 
EXECUTIVE OFFICER, DIRECTOR
COMPUGEN LTD
OLIVER 
 
FROESCHEIS 
EXECUTIVE OFFICER
COMPUGEN LTD
GILEAD 
 
HALEVY 
DIRECTOR
COMPUGEN LTD
JOHN 
 
HUNTER 
EXECUTIVE OFFICER
FLEETCOR TECHNOLOGIES INC   |  LUXOR INDUSTRIAL CORP /FI   |  COMPUGEN LTD   |  ODNB FINANCIAL CORP   |  TRINITY LEGACY DYNAMIC OPTIONS FUND I LP
ARI 
 
KRASHIN 
EXECUTIVE OFFICER
COMPUGEN LTD
ZURIT 
 
LEVINE 
EXECUTIVE OFFICER
COMPUGEN LTD
ARIE 
 
OVADIA 
DIRECTOR
SHAMROCK ISRAEL GROWTH FUND II, L.P.   |  COMPUGEN LTD
ERAN 
 
PERRY 
DIRECTOR
COMPUGEN LTD
KINNERET 
LIVNAT 
SAVITZKY 
DIRECTOR
COMPUGEN LTD
PAUL 
 
SEKHRI 
DIRECTOR
ARYX THERAPEUTICS, INC.   |  MACROGENICS INC   |  PATIENTSAFE SOLUTIONS, INC.   |  TANDEM DIABETES CARE INC   |  LYCERA CORP   |  PETRA PHARMA CORP   |  LIKEMINDS, INC./DE   |  COMPUGEN LTD   |  ALPINE IMMUNE SCIENCES, INC.   |  EGENESIS, INC.   |  ADITUM BIO FUND 1, L.P.   |  BIOMX INC.   |  AXCELLA HEALTH INC.
YARON 
 
TURPAZ 
EXECUTIVE OFFICER
COMPUGEN LTD
SANFORD 
 
ZWEIFACH 
DIRECTOR
LYRIC PHARMACEUTICALS INC.   |  COMPUGEN LTD   |  PALLADIO BIOSCIENCES, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-11-22
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2021-11-10 
2018-10-16
D
Link
OTHER 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2018-10-11 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#